Reply to Rahbar K et al.
Department of Nuclear Medicine, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India.
Madhav Prasad
MP
Yadav
Department of Nuclear Medicine, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India.
Sanjana
S
Ballal
Department of Nuclear Medicine, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India.
Madhavi
M
Tripathi
Department of Nuclear Medicine, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India. csbal@hotmail.com.
Chandrasekhal
C
Bal
D001859:Bone Neoplasms / Q000532:radiotherapy* / Q000556:secondary*; D004151:Dipeptides / Q000627:therapeutic use*; D006573:Heterocyclic Compounds, 1-Ring / Q000627:therapeutic use*; D006801:Humans; D008187:Lutetium; D008297:Male; D017063:Outcome Assessment, Health Care / Q000379:methods*; D017430:Prostate-Specific Antigen; D064129:Prostatic Neoplasms, Castration-Resistant / Q000532:radiotherapy*; D019275:Radiopharmaceuticals / Q000627:therapeutic use; D011878:Radiotherapy / Q000379:methods*; D016896:Treatment Outcome
C000610110:Pluvicto; D004151:Dipeptides; D006573:Heterocyclic Compounds, 1-Ring; D019275:Radiopharmaceuticals; D008187:Lutetium; D017430:Prostate-Specific Antigen
BJU Int. 2011 Jan;107(2):234-9
20590545
J Nucl Med. 2015 Jun;56(6):914-20
25883127
J Clin Oncol. 2008 Mar 1;26(7):1148-59
18309951
J Nucl Med. 2009 May;50 Suppl 1:122S-50S
19403881
J Nucl Med. 2006 Jun;47(6):901-3
16741296
J Nucl Med. 2016 Nov;57(11):1720-1725
27261520
J Nucl Med. 2016 Jul;57(7):1006-13
26795286
Radiat Oncol. 2010 Sep 16;5:80
20846422
Cancer. 2007 Oct 15;110(8):1738-44
17786947
Eur J Nucl Med Mol Imaging. 2017 Jan;44(1):81-91
27506431
Eur J Nucl Med Mol Imaging. 2013 May;40(5):800-16
23389427
J Clin Oncol. 2006 Jul 10;24(20):3282-92
16829652